Delivering Trio Germline Whole Genome Sequencing to Patients Newly Diagnosed With Childhood Cancer: Healthcare Professionals' Perspectives of the PREDICT Study
Cancer Medicine · 2025-02 · 14 (4)
DOI: 10.1002/cam4.70680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 14.02.2025. Verfasst von Jacqueline D Hunter und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynaecology and Newborn Health, Royal Women's Hospital, Melbourne Medical School, Faculty of Medicine, Dentistry and Health…. Hauptthemen laut MEDLINE: Neoplasms, Health Personnel, Germ-Line Mutation, Whole Genome Sequencing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Luminesce Alliance - Innovation for Children's Health, Cancer Institute NSW, Australian Government Research and Training Program (RTP) Scholarship.
Abstract (Originalsprache)
Background
Germline genomic sequencing (GS) is increasingly offered to children with cancer. To optimize integration into routine care, assessment of implementation barriers and a better understanding of healthcare professionals' perspectives and experiences are needed.
Methods
Healthcare professionals delivered trio germline GS to newly diagnosed pediatric and adolescent patients with cancer via the PREDICT completed questionnaires with qualitative and quantitative items. Each study site recorded reasons for eligible families' nonenrolment in PREDICT to identify barriers to recruitment. Quantitative data were analyzed via descriptive statistics, whereas qualitative data underwent inductive content analysis, with results integrated for interpretation.
Results
Thirty‐three healthcare professionals participated, including 23 oncology professionals and 10 genetic professionals. Healthcare professionals perceived PREDICT as beneficial to participating and future families, and that perceptions of personal benefit and altruism were drivers of family uptake. Concerns included workforce capacity and potential family distress given the trio design and high‐stress diagnosis setting. Barriers to recruitment related to clinical decision‐making, family factors, and logistics. Although most rated their genetics/genomics knowledge as “good,” regarding germline results, few were “very confident” interpreting (29%), explaining (32%), making treatment recommendations (9.7%), and providing psychosocial support to families (29%). They acknowledged a need for further training in these areas for trainees; yet, fewer were interested in training for themselves.
Conclusion
Successful implementation of routine germline GS will require targeted strategies to address logistical issues and alleviate potential negative psychosocial impacts for families. Recognizing the escalating demand on genetics experts, upskilling of the current workforce and involvement of a broader spectrum of healthcare professionals are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics, Gynaecology and Newborn Health, Royal Women's Hospital, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
- School of Clinical Medicine, Randwick Clinical Campus, Discipline of Paediatrics and Child Health, UNSW Sydney, Sydney, New South Wales, Australia.
- Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Sydney, New South Wales, Australia.
- Hereditary Cancer Centre, Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
- Prince of Wales Clinical School, UNSW Sydney, Randwick, New South Wales, Australia.
- Kids Cancer Centre, Sydney Children's Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Jacqueline D Hunter, Kate Hetherington, Brittany C McGill, Bhavna Padhye
Förderung
- Luminesce Alliance - Innovation for Children's Health
- Cancer Institute NSW
- Australian Government Research and Training Program (RTP) Scholarship
- National Health and Medical Research Council
- The Kid's Cancer Project Col Reynolds PhD Top-Up Scholarship
Zitieren
APA
Hunter, J. D., Hetherington, K., Wakefield, C. E., Tucker, K. M., McGill, B. C., Grant, A., Fuentes-Bolanos, N. A., Padhye, B., Gleeson, M., Bhatia, K., & Peate, M. (2025). Delivering Trio Germline Whole Genome Sequencing to Patients Newly Diagnosed With Childhood Cancer: Healthcare Professionals' Perspectives of the PREDICT Study. Cancer Medicine, 14(4). https://doi.org/10.1002/cam4.70680
Vancouver
Hunter JD, Hetherington K, Wakefield CE, Tucker KM, McGill BC, Grant A, et al. Delivering Trio Germline Whole Genome Sequencing to Patients Newly Diagnosed With Childhood Cancer: Healthcare Professionals' Perspectives of the PREDICT Study. Cancer Medicine. 2025;14(4). doi:10.1002/cam4.70680
BibTeX
@article{Hunter2025,
author = {Hunter, Jacqueline D and Hetherington, Kate and Wakefield, Claire E and Tucker, Katherine M and McGill, Brittany C and Grant, Andrew and Fuentes-Bolanos, Noemi A and Padhye, Bhavna and Gleeson, Margaret and Bhatia, Kanika and Peate, Michelle},
title = {Delivering Trio Germline Whole Genome Sequencing to Patients Newly Diagnosed With Childhood Cancer: Healthcare Professionals' Perspectives of the PREDICT Study},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {4},
doi = {10.1002/cam4.70680}
}
EUVIMED